Biography
Carla represents clients before the U.S. antitrust agencies, and has significant experience in government investigations before the Federal Trade Commission (FTC) and the Department of Justice (DOJ), as well as experience with administrative, Part III litigation before the FTC. Her experience encompasses a wide-range of industries, including private equity, consumer products, construction materials, oil and related exploration products and services, veterinary clinics, gasoline, pharmaceuticals, medical devices, health care, energy, defense, and sports teams.
Carla is active in leadership of the American Bar Association Antitrust Section, and is currently serving as Co-Chair of Committee Operations and a member of the Nominating Committee, and most recently served as Co-Chair of the Mergers & Acquisitions Committee. Carla has been recommended by The Legal 500 as an antitrust attorney that “does an excellent job,” and selected for inclusion in the Washington, D.C. Super Lawyers-2018-2020, and the Washington, D.C. Super Lawyers-Rising Stars Edition 2013-2015.
Key Representations*
- Pacific Avenue Capital Partners in its acquisition of Sogefi’s filtration business
- General Atlantic’s BeyondNetZero Fund on its pending investment in GRESB
- Arcosa, Inc. in its $180 million acquisition of Ameron Pole Products
- Cove Hill Partners in its strategic investment in Incident IQ
- Sunoco LP in its pending $7.3B acquisition of NuStar
- Digital Realty, Inc. in a successful resolution of relationship with Cyxtera
- Cedar Fair, L.P. in its pending $8B merger with Six Flags
- Securing U.S. antitrust clearance for Forterra, Inc. in its sale to Quikrete
- Platinum Equity in its acquisition of HarbisonWalker International, Inc.
- SK Capital in its acquisition of Apotex
- L Catterton’s Beauty Industry Group in its acquisition of BELLAMI Hair
- TPG Rise in its acquisition of Element, and merger of Bluesource with Element
- Oaktree Transportation Infrastructure Group in its strategic partnership with AIP in Rand
- Guidon Operating LLC in the divestiture of all leasehold interests and related assets to Diamondback Energy, Inc. for a mixture of cash and shares of Diamondback common stock
- Janus International Group, Inc. in its acquisition of DBCI
- L Catterton-led consortium in its acquisition of Truck Hero, Inc.
- Donuts Inc. in its acquisition of Afilias, Inc.
- Insignia Capital Group and its portfolio company Truco Enterprises in Truco’s sale to Utz Brands, Inc.
- WPX Energy, Inc. in its $12 billion all-stock merger of equals with Devon Energy Corporation
- L Catterton in its US$250 million investment in Jio Platforms, a next-generation Indian technology company and subsidiary of Reliance Industries
- Blackstone in its $22 billion merger of Kronos Incorporated and Ultimate Software
- Hilcorp Alaska in its $5.6 billion acquisition of BP’s upstream and midstream business in Alaska
- FastMed Holdings I, LLC and certain of its affiliates (“FastMed”) in their deleveraging transaction.
- Callon Petroleum Company in its $3.2 billion acquisition of Carrizo Oil & Gas, Inc.
- C&J Energy Services in an approximately $1.8 billion merger-of-equals with Keane Group
- Mycom Group Limited in its sale to Inflexion Private Equity
- Clearlake Capital Group in its acquisition of Team Technologies Holding Company
- Lovell Minnick Partners in its majority investment in SRS Acquiom
- Clearlake Capital Group in its sale of Sage Automotive Interiors
- Shermco Industries in its sale to Gryphon Investors
- Cyanco International, LLC in its acquisition by Cerberus Capital Management L.P.
- OmniClaim, a healthcare cost containment and payment integrity solutions provider, in its sale to Equian, a portfolio company of New Mountain Capital
*includes matters handled prior to joining Weil
Speaking Engagements, Latest Thinking, Firm News & Announcements
Speaking Engagements
-
Initial Reactions to the New HSR Rules and Form
Speaker(s):
Carla A. R. Hine
October 16, 2024 — Weil Antitrust counsel Carla Hine served as panelist on a webinar hosted by the Antitrust Law Section of the ABA to discuss the newly announced and long-awaited Final HSR Rules.
-
Our Curious Amalgam -- #282 Has the Scrutiny Reached a Fever Pitch? Taking the Temperature of Private Equity in Healthcare
Speaker(s):
Carla A. R. Hine
July 15, 2024 — Weil Antitrust counsel Carla Hine served as a guest panelist on the ABA’s “Curious Amalgam” podcast where she discussed the role PE plays in health care transactions and what antitrust enforcers’ recent focus means for such transactions.
Latest Thinking
- FTC and DOJ Announce Final Rulemaking for Overhaul of HSR Premerger Notification Filings and Reinstate Early Termination Alert — Antitrust — By Brianne Kucerik, Jeffrey H. Perry, Michael Moiseyev, Carla A. R. Hine, Michael C. Naughton, Marie-Marie O. de Fays and Dan S. Nobil — PDF — October 11, 2024
- Adjustments to the HSR Act Filing Thresholds, Fee Structure and Civil Penalties, and Adjustments to Clayton Act Section 8 Thresholds Alert — Antitrust — By Carla A. R. Hine, Michael C. Naughton, Dan S. Nobil and Marie-Marie O. de Fays — PDF — January 23, 2024
Firm News & Announcements
- Weil Advises Aterian Investment Partners in Partnership with Outlook Group Deal Brief — November 06, 2024
- Weil Advises Nexa Equity and Autura on Merger with Traxero Deal Brief — October 18, 2024